A Randomized Controlled Trial of Robotic Versus Open Surgery for Early Stage Cervical Cancer (ROCC)
A Randomized Controlled Trial of Robotic Versus Open Surgery for Early Stage Cervical Cancer (ROCC)
This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.
This is a multi-center, open-label, randomized, non-inferiority clinical trial with the hypothesis that robotically assisted hysterectomy with tumor containment prior to colpotomy is non-inferior to abdominal hysterectomy with respect to disease free survival.
At the commencement of surgery, a thorough inspection of all peritoneal surfaces should be performed. The location of any suspected metastatic disease should be documented in the operative report and a biopsy should be performed to confirm the diagnosis. If intraperitoneal disease is detected, the radical hysterectomy should be abandoned. In patients with macroscopic evidence of metastatic disease to the lymph nodes, intraoperative frozen section should be performed to confirm the presence of metastatic disease. Intraoperative management will be left to the discretion of the surgeon. Patients who have confirmed macroscopic lymph node metastases intraoperatively will be excluded from final analysis and replaced due to the controversy surrounding the decision to perform a radical hysterectomy in this setting. Patients in whom the hysterectomy is abandoned will be deemed non-evaluable and excluded from final analysis and will be replaced. For all patients, the surgeon should document operative time from incision to close, detailed description of operative findings, intraoperative complications, and blood loss. For patients randomized to the robotic arm, the surgeon should document the use of and specify the type of vaginal manipulator and the reason for conversion to laparotomy (if applicable). Transcervical manipulators are not permitted.
Standard arm: Radical or simple hysterectomy is performed as per standard technique (peon radical hysterectomy (Piver type 2 or 3 or Querleu & Morrow Type B or C) with salpingectomy +/- oophorectomy. Ovaries may be removed or preserved +/- transposition. Prior to colpotomy, the vagina must be closed over the tumor (ie, Wertheim clamps, contour stapling device).
Study arm: Radical or simple hysterectomy is performed as per standard robotic technique (Querleu & Morrow Type B or C) with salpingectomy +/- oophorectomy. Ovaries may be removed or preserved +/- transposition. Colpotomy may be made intracorporally or vaginally. Vagina must be closed prior to intracorporeal colpotomy (see below, #10)
Inclusion Criteria:
Patient must have histologically confirmed adenocarcinoma (usual/classic/NOS), squamous cell carcinoma, adenosquamous carcinoma (Including glassy cell)
Patient must be FIGO Stage IA2, IBI, IB2 (2018 staging) without evidence of definitive parametrial, vaginal, nodal or distant metastases on exam or imaging. Patients with tumor size less than or equal to 4 cm confirmed on MRI prior to randomization are eligible.
Patient must have uterine size <12 cm AND felt to be appropriate for vaginal delivery of the specimen per investigator.
Patient must be suitable surgical candidate with preoperative assessments such as labs and EKG performed per institutional standard and agree to be randomized to undergo open or robotic radical (or simple) hysterectomy.
NOTE: Simple hysterectomy will be allowed in patients who meet the following criteria:
Submission of source documents in the GOG Partners Source Document Portal will be required prior to randomization for review and confirmation of simple hysterectomy being met (see Section 6.0 for instructions).
Patient must be age 18 years or older.
Patient must have ECOG performance status 0-1.
Patient must have a negative urine pregnancy test within 30 days of surgery in pre-menopausal women.
Patient must have signed an approved informed consent and authorization permitting the release of personal health information.
Exclusion Criteria:
schhab@gog.org215-854-0770
smatkin@gog.org801-661-1584
Duarte, California 91010, United States
RTinsley@coh.org
Encinitas, California 92024, United States
Irvine, California 92618, United States
La Jolla, California 92037, United States
La Jolla, California 92093, United States
San Diego, California 92103, United States
San Francisco, California 91409, United States
Hartford, Connecticut 06106, United States
New Britain, Connecticut 06053, United States
Jacksonville, Florida 32204, United States
Orlando, Florida 32806, United States
Shreveport, Louisiana 71118, United States
Scarborough, Maine 04074, United States
Minneapolis, Minnesota 55455, United States
Minneapolis, Minnesota 55455, United States
Albuquerque, New Mexico 87131, United States
Brightwaters, New York 11718, United States
Brooklyn, New York 11220, United States
New Hyde Park, New York 11040, United States
New York, New York 10016, United States
New York, New York 10016, United States
New York, New York 10029, United States
New York, New York 10065, United States
Cincinnati, Ohio 45220, United States
Cincinnati, Ohio 45220, United States
Columbus, Ohio 43210, United States
Columbus, Ohio 43212, United States
Columbus, Ohio 43221, United States
Columbus, Ohio 43221, United States
Lewis Center, Ohio 43035, United States
Westerville, Ohio 43081, United States
Portland, Oregon 97210, United States
Tualatin, Oregon 97062, United States
Philadelphia, Pennsylvania 19104, United States
Providence, Rhode Island 02905, United States
Dallas, Texas 75390, United States
Dallas, Texas 75390, United States
Dallas, Texas 75390, United States
The Woodlands, Texas 77380, United States
Charlottesville, Virginia 22903, United States
Richmond, Virginia 23219, United States
Tappahannock, Virginia 25560, United States
Vancouver, Washington 98686, United States
São José do Rio Preto, São Paulo 15090-000, Brazil
aocronin@health.ucsd.edu
rtinsley@coh.org
aocronin@health.ucsd.edu
aocronin@health.ucsd.edu
dmchase@mednet.ucla.edu
ana.navarrete@hoag.org
ana.navarrete@hoag.org
skonda@stanford.edu
aocronin@health.ucsd.edu
rtinsley@coh.org
aocronin@health.ucsd.edu
mailto:siobhan.reilly@hhchealth.org
mailto:siobhan.reilly@hhchealth.org
mailto:siobhan.reilly@hhchealth.org
mailto:siobhan.reilly@hhchealth.org
nicole.antenucci@ascension.org
Jennifer.mosley@hcahealthcare.com
jacquelile@baptisthealth.net
Stephany.FuentesAngulo@baptisthealth.net
Jennifer.mosley@hcahealthcare.com
jacquelile@baptisthealth.net
Stephany.FuentesAngulo@baptisthealth.net
agoebel@augusta.edu
lauren.higgins@bhsi.com
lauren.higgins@bhsi.com
dbrack@lsuhsc.edu
ckay@wkhs.com
donovr@mmc.org
jessica.thomespepin@usoncology.com
eezielin@umn.edu
eezielin@umn.edu
crystal.tindall@mercy.net
spierpoint@cohreno.com
andersj@mskcc.org
andersj@mskcc.org
mailto:bmubashar@northwell.edu
mailto:bmubashar@northwell.edu
mailto:Kathryn.Allen@nyulangone.org
mailto:Kathryn.Allen@nyulangone.org
mailto:Kathryn.Allen@nyulangone.org
andersj@mskcc.org
andersj@mskcc.org
mailto:bmubashar@northwell.edu
andersj@mskcc.org
mailto:bmubashar@northwell.edu
mailto:bmubashar@northwell.edu
mailto:Kathryn.Allen@nyulangone.org
mailto:Kathryn.Allen@nyulangone.org
mailto:Kathryn.Allen@nyulangone.org
Kuneha.kumarley@mssm.edu212-824-7859
andersj@mskcc.org
mailto:andersj@mskcc.org
andersj@mskcc.org
kashah@novanthealth.org
taylor.hayes@duke.edu
taylor.hayes@duke.edu
lauren.march@duke.edu
kashah@novanthealth.org
kashah@novanthealth.org
kashah@novanthealth.org
kashah@novanthealth.org
kashah@novanthealth.org
kashah@novanthealth.org
kashah@novanthealth.org
mccutcheond@summahealth.org
mamccutcheond@summahealth.org
Lauren.Patrick@uhhospitals.org
callan.myerscough@osumc.edu
callan.myerscough@osumc.edu
callan.myerscough@osumc.edu
callan.myerscough@osumc.edu
callan.myerscough@osumc.edu
callan.myerscough@osumc.edu
callan.myerscough@osumc.edu
callan.myerscough@osumc.edu
callan.myerscough@osumc.edu
macallan.myerscough@osumc.edu
julie.carstens@ketteringhealth.org
callan.myerscough@osumc.edu
callan.myerscough@osumc.edu
mailto:morgan-hays@ouhsc.edu
Nora.Auston@providence.org
ashley.douglas@jefferson.edu
christine.yang@pennmedicine.upenn.edu
yauchj@upmc.edu
janke.mainsmason@ahn.org
ashley.douglas@jefferson.edu
mark.shahin@usoncology.com
ajohn@wihri.org
Kimberly.Donelson@erlanger.org
jowalker@westclinic.com901-683-0055
kelli.watkins@mckesson.com
mailto:nori.sullivan@usoncology.com
mailto:Sarah.Wade@usoncology.com
christine.terraciano@usoncology.com214-370-1000
mailto:Annette.Paulsen@UTSouthwestern.edu
Annette.Paulsen@UTSouthwestern.edu
Annette.Paulsen@UTSouthwestern.edu
mailto:Annette.Paulsen@UTSouthwestern.edu
mailto:nori.sullivan@usoncology.com
mailto:nori.sullivan@usoncology.com
Riquanda.Walker@McKesson.com
Kelli.Watkins@mckesson.com
mrmc9p@hscmail.mcc.virginia.edu
rmc9p@hscmail.mcc.virginia.edu
takada.harris@inova.org
slwashington@vcu.edu
mailto:slwashington@vcu.edu
mailto:slwashington@vcu.edu
mailto:slwashington@vcu.edu
mailto:slwashington@vcu.edu
mailto:slwashington@vcu.edu
mailto:slwashington@vcu.edu
mailto:christina.martinelli@hsc.wvu.edu
mailto:christina.martinelli@hsc.wvu.edu
kostechka@wisc.edu
erik.coelho@lacog.group
atsunoda@gmail.com
renato.moretti@einstein.br
daniela.augustin@lacogcancerresearch.org
mdcarlosandrade@gmail.com
erik.coelho@lacog.group
daniela.augustin@lacogcancerresearch.org
Guitmann@clinicagincol.com.br
Vanessa.Ballin@uhn.ca
sarah.ferguson@uhn.ca
mailto:phuong-nam.nguyen@mail.mcgill.ca
mathilde.duplaix.chum@ssss.gouv.qc.ca
p06162006@cha.ac.kr
sdhwcj@naver.com
jaehoonkim@yuhs.ac
pistis@yuhs.ac
te05028@yuhs.ac
san1@yuhs.ac
shj9918@gmail.com
sjyuni105@gmail.com
kdyog@amc.seoul.kr
chelhun.choi@samsung.com
orlando@catholic.ac.kr
san1@yuhs.ac